Skip to content
← Full study record

NCT00072449 · MORE INFO

Limitations, agreements, and source contact

Rituximab in Treating Patients With Refractory or Relapsed Primary CNS Lymphoma · Source last updated 2013-08-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
Study terminated early due to slow accrual and lack of resources and priority due to NCI mandate of combining two consortia. Unable to fully analyze the data, or objectives, not enough patients. Not able to do statistics
point Of Contact
email
jfisher@jhmi.edu
organization
Johns Hopkins University
phone
410-955-3657
title
Dr. Stuart A Grossman
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
Study terminated early due to slow accrual and lack of resources and priority due to NCI mandate of combining two consortia. Unable to fully analyze the data, or objectives, not enough patients. Not able to do statistics
point Of Contact
email
jfisher@jhmi.edu
organization
Johns Hopkins University
phone
410-955-3657
title
Dr. Stuart A Grossman

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice